Insiders who reported open-market trades in the last 12 months at the companies Brian Corvese files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Barbara Ryan - $47K in INKT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Brian Corvese is a corporate insider, tracked as Director of MiNK Therapeutics, Inc. (INKT). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Brian Corvese submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
InsiderAlpha's records for Brian Corvese go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
